Ambrx, MabSpace in ADC deal

Ambrx Inc. (La Jolla, Calif.) and MabSpace Biosciences Co. Ltd. (Suzhou, China) said they plan to discover and develop antibody-drug conjugates for oncology. The partners will use MabSpace's humanized antibody technology in combination with Ambrx's EuCode conjugation platform.

The partners said they will share costs and rights to any resulting products in the global collaboration...